SCHEMBL22757174

SCHEMBL22757174

COC(=O)c1ccc2c(c1)N(C)C(=O)C2

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.60
POLB P06746 1/20 0.60
CASP3 P42574 1/20 0.51
ALDH1A1 P00352 8/20 0.48
KDM4E B2RXH2 5/20 0.48
CASP1 P29466 2/20 0.48
CASP7 P55210 2/20 0.48
HSD17B10 Q99714 2/20 0.48
ALOX15 P16050 1/20 0.48
SMYD3 Q9H7B4 1/20 0.44
LMNA P02545 2/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
XDH P47989 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24233407 0.88 SMN1; SMN2 (0.60) SMN1; SMN2POLBCASP3ALDH1A1KDM4E
SCHEMBL24633637 0.84 SMN1; SMN2 (0.49) SMN1; SMN2POLBCASP3ALDH1A1KDM4E
SCHEMBL30204261 0.83 LMNA (0.57) SMN1; SMN2POLBALDH1A1SMYD3LMNA
SCHEMBL19329581 0.83 LMNA (0.57) SMN1; SMN2POLBALDH1A1SMYD3LMNA
SCHEMBL30168113 0.82 NOTUM (0.55) SMN1; SMN2POLBCASP3ALDH1A1KDM4E
SCHEMBL2572591 0.82 NOTUM (0.55) SMN1; SMN2POLBCASP3ALDH1A1KDM4E
SCHEMBL27801761 0.81 KDM4E (0.47) SMN1; SMN2POLBALDH1A1KDM4EHSD17B10
SCHEMBL27570035 0.81 SMN1; SMN2 (0.48) SMN1; SMN2POLBCASP3ALDH1A1KDM4E
Acetic Acid SCHEMBL22437596 0.80 NOTUM (0.52) SMN1; SMN2POLBCASP3ALDH1A1KDM4E
SCHEMBL22757190 0.80 SMN1; SMN2 (0.46) SMN1; SMN2POLBCASP3ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159421-A1 SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF Kynan Duke IP, LLC (US) 2023-05-25 US disclosed
EP-3747864-A1 A METHOD FOR PREPARING METHYL (Z)-3-[[4-[METHYL[2-(4-METHYL-1-PIPERAZINYL)ACETYL]AMINO]PHENYL]AMINO]PHENYLMETHYLENE)-OXINDOLE-6-CARBOXYLATE (INTEDANIB, NINTEDANIB) ZENTIVA, K.S. (CZ) 2020-12-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159421-A1 SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF CYP8B1, HSD11B1, HSD11B2 SMN1; SMN2 3552/4885POLB 1779/4885CASP3 762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.